A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression
Seagen Inc.
Seagen Inc.
UNC Lineberger Comprehensive Cancer Center
Affimed GmbH
University of Nebraska
Henan Cancer Hospital
The First Affiliated Hospital with Nanjing Medical University
Czech Lymphoma Study Group
Samsung Medical Center
University of California, San Francisco
Eisai Inc.
Zhejiang Cancer Hospital
Lymphoma Study Association
Sun Yat-sen University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center